1.	Modafinil for the Treatment of Fatigue in Lung Cancer V1.0 Phase: Phase IV Type: Supportive care Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: Modafinil/lung/01, NCT00829322
2.	Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000069477, U10CA037420, URCC-U2901, NCI-5952, NCI-P02-0228, NCT00042848
3.	Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF) Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: DOCET_L_04203, NCT00917748
4.	Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: U2702, NCT00178373
5.	Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer Phase: No phase specified Type: Supportive care Status: Completed Age: 21 to 65 Sponsor: NCI, Other Protocol IDs: CDR0000258139, P30CA016042, UCLA-0206017, CEPHALON-UCLA-0206017, NCI-G02-2133, NCT00052286
6.	Pilot Study of Modafinil for Treatment of Fatigue in Cancer Patients Phase: No phase specified Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UVACC-HIC-10951, UVACC-30603, NCT00112515